The Global Epidemiology of Diabetes and Kidney Disease.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Chronic Kidney Disease

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.ackd.2017.10.011PMID 29580576PMCID PMC11000253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic Kidney Disease

  2019cited by this paper
• The ascending rank of chronic kidney disease in the global burden of disease study.

  2017cited by this paper
• Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality

  2017cited by this paper
• Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies

  2017cited by this paper
• The global burden of chronic kidney disease: estimates, variability and pitfalls

  2017cited by this paper
• Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort Study

  2017cited by this paper
• Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

  2017cited by this paper
• Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013

  2016cited by this paper
• Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

  2016cited by this paper
• Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.

  2016cited by this paper
• Decreasing incidence of type 2 diabetes mellitus in the United States, 2007-2012: Epidemiologic findings from a large US claims database.

  2016cited by this paper
• Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.

  2016cited by this paper
• Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?

  2016cited by this paper
• Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

  2016cited by this paper
• CKD Prevalence Varies across the European General Population.

  2016cited by this paper
• Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

  2016cited by this paper
• Trends in Prevalence of Chronic Kidney Disease in the United States.

  2016cited by this paper
• Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations

  2016cited by this paper
• High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.

  2015cited by this paper
• The global nephrology workforce: emerging threats and potential solutions!

  2015cited by this paper
• US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

  2015cited by this paper
• Diabetic kidney disease

  2015cited by this paper
• Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus.

  2015cited by this paper
• The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.

  2015cited by this paper
• Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011.

  2015cited by this paper
• Excess Mortality among Persons with Type 2 Diabetes.

  2015cited by this paper
• Diabetic nephropathy in Africa: A systematic review.

  2015cited by this paper
• Type 1 diabetes.

  2014cited by this paper
• Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

  2014cited by this paper
• Diabetic kidney disease in Australia: Current burden and future projections

  2014cited by this paper
• The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.

  2014cited by this paper
• Prevalence and Determinants of Diabetic Nephropathy in Korea: Korea National Health and Nutrition Examination Survey

  2014cited by this paper
• Epidemiology and risk factors for diabetic kidney disease.

  2014cited by this paper
• Changes in diabetes-related complications in the United States, 1990-2010.

  2014cited by this paper
• Primary Care Detection of Chronic Kidney Disease in Adults with Type-2 Diabetes: The ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease)

  2014cited by this paper
• Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.

  2014cited by this paper
• Epidemiology of diabetes

  2014cited by this paper
• Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.

  2014cited by this paper
• Diabetes: a 21st century challenge.

  2014cited by this paper
• Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.

  2014cited by this paper
• Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.

  2014cited by this paper
• Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register

  2013cited by this paper
• Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.

  2013cited by this paper
• Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China

  2013cited by this paper
• Chronic kidney disease: global dimension and perspectives

  2013cited by this paper
• Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania

  2013cited by this paper
• Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study

  2013cited by this paper
• Nephrology in Africa—not yet uhuru

  2013cited by this paper
• Kidney disease and increased mortality risk in type 2 diabetes.

  2013cited by this paper
• Incidence of type 1 diabetes in Finland.

  2013cited by this paper
• Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area

  2012cited by this paper
• Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007).

  2012cited by this paper
• Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study

  2012cited by this paper
• Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.

  2012cited by this paper
• Reduced incidence of end stage renal disease among the elderly in Denmark: an observational study

  2012cited by this paper
• Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

  2011cited by this paper
• Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review.

  2011cited by this paper
• Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

  2011cited by this paper
• The impact of disadvantage on the development and progression of diabetic kidney disease.

  2011cited by this paper
• Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program

  2011cited by this paper
• Diabetes mellitus, fasting glucose, and risk of cause-specific death.

  2011cited by this paper
• Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

  2011cited by this paper
• Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes

  2010cited by this paper
• Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.

  2010cited by this paper
• Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline

  2010cited by this paper
• In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study

  2010cited by this paper
• Epidemiology of type 1 diabetes.

  2010cited by this paper
• Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

  2010cited by this paper
• Global estimates of the prevalence of diabetes for 2010 and 2030.

  2010cited by this paper
• Relation between kidney function, proteinuria, and adverse outcomes.

  2010cited by this paper
• Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).

  2009cited by this paper
• Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).

  2009cited by this paper
• Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.

  2009cited by this paper
• Change in the Distribution of Albuminuria According to Estimated Glomerular Filtration Rate in Pima Indians With Type 2 Diabetes

  2009cited by this paper
• The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

  2009cited by this paper
• Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

  2009cited by this paper
• Patient awareness of chronic kidney disease: trends and predictors.

  2008cited by this paper
• All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

  2008cited by this paper
• CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP).

  2008cited by this paper
• High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai.

  2008cited by this paper
• Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes

  2007cited by this paper
• Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up

  2007cited by this paper
• Low glomerular filtration in the population: prevalence, associated disorders, and awareness.

  2006cited by this paper
• Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort

  2006cited by this paper
• Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999

  2006cited by this paper
• Chronic kidney disease and mortality risk: a systematic review.

  2006cited by this paper
• The 30-Year Natural History of Type 1 Diabetes Complications

  2006cited by this paper
• Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.

  2006cited by this paper
• Risk Factors for Renal Dysfunction in Type 2 Diabetes

  2006cited by this paper
• The changing epidemiology of diabetic microangiopathy in type 1 diabetes

  2005cited by this paper
• Nonalbuminuric renal insufficiency in type 2 diabetes.

  2004cited by this paper
• Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000.

  2004cited by this paper
• Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

  2004cited by this paper
• Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

  2003cited by this paper
• Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

  2003cited by this paper
• Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease and Hypertension Early Detection of Kidney Disease in Community Settings: The Kidney Early Evaluation Program (KEEP)

  2003cited by this paper
• Regression of microalbuminuria in type 1 diabetes.

  2003cited by this paper

• Association of TyG index and ALOX12 rs112667 polymorphism with T2DM and DKD in Chinese adults

  2026cites this paper
• O papel dos probióticos na modulação da microbiota intestinal como potencial inibidor da progressão da doença renal diabética

  2026cites this paper
• Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies

  2026cites this paper
• Salvia miltiorrhiza (Danshen) and its extracts in the alternative treatment of diabetic nephropathy: mechanisms and clinical perspectives.

  2026cites this paper
• Effects of social determinants of health on the landscape of kidney disease.

  2026cites this paper
• Dialysis meets devices: the use of automated insulin delivery in end stage kidney disease and haemodialysis

  2026cites this paper
• Myokine SIRPα exacerbates kidney disease in diabetes

  2026cites this paper
• Capturing the inflammatory landscape within kidney compartments of human diabetic kidney disease: a digital spatial profiling study

  2026cites this paper
• Modified Shen-Yan-Fang-Shuai formula attenuates diabetic kidney disease progression via regulation of HIF-1α-mediated mitochondrial energy metabolism

  2026influential citation
• Tracking three decades of type 1 diabetes-related chronic kidney disease in East Asia: Burden, age-sex patterns, and quality of care index.

  2026cites this paper
• Malathion and metformin in forensic entomotoxicology: a narrative review on impacts on necrophagous fly development and key research gaps

  2026cites this paper
• The role of probiotics in modulating the gut microbiota as a potential inhibitor of diabetic kidney disease progression

  2026cites this paper
• The neutrophil percentage to albumin ratio as a predictor of all-cause and cardiovascular mortality in patients with diabetic kidney disease: A longitudinal cohort analysis of NHANES 2009 to 2018

  2026cites this paper
• Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes.

  2026cites this paper
• Multimodal psychological intervention improves psychological well-being and inflammatory profiles in patients with diabetic nephropathy.

  2026cites this paper
• Intravascular Lithotripsy for Calcified Femoropopliteal Artery Disease: A Pooled Analysis of Randomized Trials in a Chinese Population

  2026cites this paper
• Awareness and Perceived Risk Factors of Chronic Kidney Disease Among Patients with Diabetes in the Northern Borders of Saudi Arabia: Implications for a Strategic Monitoring and Management Plan.

  2026cites this paper
• Proteomic profiling of arteriovenous fistula tissue identifies dysregulated oxidoreductase proteins in diabetic end-stage renal disease

  2026cites this paper
• Next-generation therapeutics for diabetic kidney disease.

  2026cites this paper
• High-Throughput Screening of Natural Products Alleviating Diabetic Nephropathy Using a Peroxynitrite (ONOO-) Responsive Fluorescent Probe.

  2026cites this paper
• Association of growth differentiation factor-15 with renal disease outcomes and all-cause death in type 1 and type 2 diabetic patients: a meta-analysis

  2025influential citation
• GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity

  2025cites this paper
• Progression of Diabetic Nephropathy in Patients with Uncontrolled Type 2 Diabetes Mellitus

  2025cites this paper
• Utility of carbon dots for diabetes treatment and management: A mini review.

  2025cites this paper
• Role of novel biomarkers urinary NGAL and MCP-1 in predicting progression of diabetic kidney disease in type 2 DM

  2025cites this paper
• Impact of Denosumab Adherence on Renal Function and Mortality Rates in Type 2 Diabetes Patients With Osteoporosis.

  2025cites this paper
• Inibidores do Cotransportador Sódio-Glicose 2 em Receptores de Transplante Renal Diabéticos: Impacto no Controle Glicêmico, Função do Enxerto e Proteinúria

  2025cites this paper
• Metabolomic etiological insights into six diabetic complications: a large scale Mendelian randomization atlas with colocalization validation.

  2025cites this paper
• Metformin attenuates O-GlcNAc modification to improve renal function via AMPK/mTOR signaling in diabetic nephropathy

  2025cites this paper
• Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease

  2025cites this paper
• Relationship between flow-mediated dilation and urinary albumin-creatinine ratio in patients with type 2 diabetes mellitus.

  2025cites this paper
• The Impact of Donor and Recipient Diabetes on Patient and Graft Survival in Kidney Transplant Recipients

  2025cites this paper
• Trends in chronic kidney disease-related mortality in older adults in the United States from 1999 to 2020: a cross-sectional study

  2025cites this paper
• Comment on "Analysis of acute glomerulonephritis disease burden and incidence trends in China, 1990-2021".

  2025cites this paper
• Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018

  2025cites this paper
• Triglyceride glucose-body mass index is associated with diabetic kidney disease in type 2 diabetes mellitus patients without non-alcoholic fatty liver disease

  2025cites this paper
• Glycosylation in kidney diseases

  2025cites this paper
• The trajectory of frailty index and its association with rapid decline in kidney function and the incidence of chronic kidney disease: evidence from the China health and retirement longitudinal study

  2025cites this paper
• Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification

  2025cites this paper
• C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study

  2025influential citation
• Analysis of research trends and development prospects of soluble guanylate cyclase stimulators/activators: using bibliometric methods

  2025cites this paper
• Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring

  2025cites this paper
• Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study

  2025cites this paper
• Effectiveness of semaglutide on survival outcomes in patients with type 2 diabetes and chronic kidney disease

  2025cites this paper
• Ribosomes under stress: GCN2 integrates translational dysfunction and pain signaling.

  2025cites this paper
• Cardiometabolic risk phenotypes and chronic kidney disease incidence in older adults: a nationwide longitudinal cohort study

  2025cites this paper
• Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years

  2025cites this paper
• The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database.

  2025cites this paper
• The global incidence rate of type 2 diabetes related chronic kidney disease and predictions by Bayesian age-period-cohort analysis: findings from the Global Burden of Disease Study 2019

  2025cites this paper
• Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021

  2025cites this paper
• Real-world implementation of the 2020 KDIGO guidelines for diabetes management in chronic kidney disease: a single-center retrospective study

  2025cites this paper
• The role of vegan meat as an alternative protein source in chronic kidney disease: a narrative review

  2025cites this paper
• LAMC1 aggravates diabetic retinopathy through PI3K/AKT signaling-regulated epithelial-mesenchymal transition in retinal pigment epithelial cells

  2025cites this paper
• Global burden and trends of chronic kidney disease due to type 2 diabetes mellitus caused by dietary risks: insights from the global burden of disease study 2021

  2025influential citation
• Accelerated biological aging and homeostatic dysregulation in diabetic kidney disease: Evidence from NHANES and Mendelian randomization

  2025cites this paper
• Diabetic Kidney Disease‐Associated Pathological Angiogenesis: The Role of Aquaporin‐1

  2025cites this paper
• Understanding the burden and associated risk factors of type 2 diabetes mellitus among middle-aged and aging population in Yangon, Myanmar: a cross-sectional analytical study

  2025cites this paper
• Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data

  2025cites this paper
• The possible renoprotective effect of denatonium benzoate in a rat model of type 2 diabetes: role of Krüppel-like factor 6 (KLF6).

  2025cites this paper
• Mapping systemic inter-organ metabolic networks across glycemic continuum using whole-body [18F]FDG PET/CT and machine learning

  2025cites this paper
• Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD Trial

  2025cites this paper
• Expanding the Therapeutic Landscape: Sodium-Glucose Co-transporter 2 Inhibitors in Kidney Transplant Recipients

  2025cites this paper
• Diabetic retinopathy and diabetic kidney disease, either isolated or associated, impact on the 10-year risk of cardiovascular disease: are we dealing with similar conditions?

  2025influential citation
• Spexin peptide ameliorates renal injury in diabetic nephropathy rat model via modulation of metabolic, oxidative, inflammatory, and apoptotic dysregulations

  2025cites this paper
• Evaluation of Serum GPR-120 Levels in Diabetic Patients With and Without Nephropathy: A Comparative Study on Lipid and Renal Parameters

  2025cites this paper
• Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications

  2025cites this paper
• Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study

  2025influential citation
• ABCDE to identify and prevent chronic kidney disease: a call to action

  2025cites this paper
• Non-enzymatic modification of aminophospholipids induces angiogenesis, inflammation, and insulin signaling dysregulation in human renal glomerular endothelial cells.

  2025cites this paper
• Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications

  2025cites this paper
• Screening of Methylglyoxal Fluctuations in the Kidneys of Diabetic Nephropathy Mice Using a Europium(III) Complex-Based Dual-Mode Luminescence Probe.

  2025cites this paper
• Reduced glomerular filtration rate in individuals with intermediate hyperglycemia and type 2 diabetes as defined by 1-hour post-load glucose levels according to the newly released IDF criteria.

  2025cites this paper
• Molecular mechanisms underlying the effects of beta-sitosterol on TGF-β1/Nrf2/SIRT1/p53-mediated signaling in the kidney of a high-fat diet and sucrose-induced type-2 diabetic rat.

  2025cites this paper
• Empagliflozin attenuates renal damage in diabetic nephropathy by modulating mitochondrial quality control via Prdx3-PINK1 pathway.

  2025cites this paper
• Protective effect of Astragalus polysaccharide on diabetic nephropathy: A systematic review and meta‑analysis reveals the efficacy and potential mechanisms

  2025cites this paper
• Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetes

  2025cites this paper
• Potential Effects of Omega-3 Fatty Acids on Type 1 Diabetes in Preventing Alzheimer’s Disease Progression

  2025cites this paper
• The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health

  2025cites this paper
• Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia

  2025cites this paper
• Emerging trends and disparities in cardiovascular, kidney, and diabetes-related mortality: A retrospective analysis of the wide-ranging online data for epidemiologic research database

  2025cites this paper
• The impact of clinical history on the predictive performance of machine learning and deep learning models for renal complications of diabetes

  2025cites this paper
• Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational study

  2025cites this paper
• Therapeutic role of Crateva religiosa in diabetic nephropathy: Insights into key signaling pathways

  2025cites this paper
• Multimorbidity patterns and early signals of diabetes in online communities

  2025cites this paper
• Association between systemic inflammatory indicators on admission and mortality in critically ill patients with diabetic kidney disease based on the MIMIC-IV database: a cohort study

  2025cites this paper
• Mesangial angiogenesis and interstitial eosinophilic infiltration in diabetic nephropathy are associated with elevated CD248 expression

  2025cites this paper
• Performance of the Kidney Failure Risk Equation according to diabetic status in the CKD-CAREMEAU cohort of patients with chronic kidney disease

  2025cites this paper
• The association of visceral adiposity index and diabetic kidney disease in elderly patients with type 2 diabetes mellitus: a cross-sectional study

  2025cites this paper
• Association of finerenone with prognosis and safety in diabetic kidney disease patients: an undated meta-analysis based on four RCTs

  2025cites this paper
• Association between cardiovascular–kidney–metabolic health and rheumatoid arthritis prevalence: A cross-sectional study

  2025cites this paper
• Effects of oral semaglutide on kidney outcomes in people with type 2 diabetes: a nationwide, multicentre, retrospective, observational study (Renal_ENDO2S-RWD substudy)

  2025cites this paper
• Research on TCM Comprehensive Treatment of DKD Based on Pathophysiological Mechanism

  2025cites this paper
• Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes

  2025cites this paper
• CLCF1 contributes to high-glucose-induced EndMT by modulating JAK2/STAT3 signaling

  2025influential citation
• Curcumin/piperine modulates the butyrate levels and alleviates diabetic kidney disease via Nrf2/HO-1 signaling pathway

  2025cites this paper
• Acute myocardial infarction treatment delay in South Asia: a systematic review and meta-analysis.

  2025cites this paper
• Analysis of acute glomerulonephritis disease burden and incidence trends in China, 1990–2021

  2025cites this paper
• Clinical outcomes of and risk factors for normoalbuminuric diabetic kidney disease.

  2025cites this paper
• Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis

  2025cites this paper
• The role of endothelin receptor antagonists in kidney disease

  2025cites this paper